[go: up one dir, main page]

MX2016010967A - Nuevas composiciones para tratar lesiones neuronales mecanicas. - Google Patents

Nuevas composiciones para tratar lesiones neuronales mecanicas.

Info

Publication number
MX2016010967A
MX2016010967A MX2016010967A MX2016010967A MX2016010967A MX 2016010967 A MX2016010967 A MX 2016010967A MX 2016010967 A MX2016010967 A MX 2016010967A MX 2016010967 A MX2016010967 A MX 2016010967A MX 2016010967 A MX2016010967 A MX 2016010967A
Authority
MX
Mexico
Prior art keywords
new compositions
neuronal injuries
mechanical neuronal
treat mechanical
treat
Prior art date
Application number
MX2016010967A
Other languages
English (en)
Other versions
MX373808B (es
Inventor
Cohen Daniel
Chumakov Ilya
Nabirochkin Serguei
Original Assignee
Pharnext
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/187,841 external-priority patent/US9393241B2/en
Application filed by Pharnext filed Critical Pharnext
Publication of MX2016010967A publication Critical patent/MX2016010967A/es
Publication of MX373808B publication Critical patent/MX373808B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a composiciones y a procedimientos para el tratamiento de las lesiones neuronales mecánicas.
MX2016010967A 2014-02-24 2015-02-23 Nuevas composiciones para tratar lesiones neuronales mecánicas. MX373808B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/187,841 US9393241B2 (en) 2009-06-02 2014-02-24 Compositions for treating CMT and related disorders
PCT/EP2015/053700 WO2015124763A1 (en) 2014-02-24 2015-02-23 New compositions for treating mechanical neuronal injuries

Publications (2)

Publication Number Publication Date
MX2016010967A true MX2016010967A (es) 2016-11-29
MX373808B MX373808B (es) 2020-03-24

Family

ID=52669585

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016010967A MX373808B (es) 2014-02-24 2015-02-23 Nuevas composiciones para tratar lesiones neuronales mecánicas.

Country Status (14)

Country Link
EP (1) EP3110411B1 (es)
JP (1) JP6522641B2 (es)
KR (1) KR20160126045A (es)
CN (1) CN106456571B (es)
AU (1) AU2015220717B2 (es)
BR (1) BR112016019395A2 (es)
CA (1) CA2940442C (es)
EA (1) EA201691703A1 (es)
ES (1) ES2774373T3 (es)
IL (1) IL246919B (es)
MX (1) MX373808B (es)
SG (1) SG11201606485VA (es)
UA (1) UA118785C2 (es)
WO (1) WO2015124763A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018076060A1 (en) 2016-10-26 2018-05-03 Genea Ip Holdings Pty Ltd Improved generation of muscle lineage cells and therapeutic uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070099947A1 (en) * 2005-11-03 2007-05-03 Alkermes, Inc. Methods and compositions for the treatment of brain reward system disorders by combination therapy
US20080255062A1 (en) * 2007-02-13 2008-10-16 University Of Manitoba Axon regeneration from adult sensory neurons
EP2065038A1 (en) * 2007-11-30 2009-06-03 Pharnext New therapeutic approaches for treating Charcot-Marie-Tooth disease
EP2135607A1 (en) * 2008-06-18 2009-12-23 Pharnext Combination of pilocarpin and methimazol for treating Charcot-MarieTooth disease and related disorders
EP2263665A1 (en) * 2009-06-02 2010-12-22 Pharnext New compositions for treating CMT and related disorders

Also Published As

Publication number Publication date
EA201691703A1 (ru) 2017-04-28
CA2940442C (en) 2022-04-12
SG11201606485VA (en) 2016-09-29
JP2017507941A (ja) 2017-03-23
BR112016019395A2 (pt) 2017-10-24
IL246919B (en) 2020-04-30
UA118785C2 (uk) 2019-03-11
IL246919A0 (en) 2016-09-29
CA2940442A1 (en) 2015-08-27
MX373808B (es) 2020-03-24
ES2774373T3 (es) 2020-07-20
JP6522641B2 (ja) 2019-05-29
WO2015124763A1 (en) 2015-08-27
AU2015220717A1 (en) 2016-08-25
AU2015220717B2 (en) 2020-03-26
CN106456571B (zh) 2021-07-27
EP3110411B1 (en) 2019-11-06
EP3110411A1 (en) 2017-01-04
KR20160126045A (ko) 2016-11-01
CN106456571A (zh) 2017-02-22

Similar Documents

Publication Publication Date Title
IL285151B1 (en) Methods for the treatment of fgf21-related disorders
BR112017006664A2 (pt) terapias de combinação
MX2019003623A (es) Composiciones y metodos para el tratamiento de afecciones oftalmicas.
BR112018010464A8 (pt) formulações farmacêuticas tópicas para tratar condições inflamatórias relacionadas
PT3889145T (pt) 8-ciano-5-piperidino-quinolinas como antagonistas de tlr7/8 e suas utilizações para tratamento de distúrbios imunitários
ZA201605715B (en) Cyclopropylamines as lsd1 inhibitors
PL3265053T3 (pl) Sposoby leczenia skóry
UY37018A (es) Inhibidores bicíclicos de pad4
BR112017011771A2 (pt) métodos e composições para o tratamento de câncer
PT3377516T (pt) Composição para o tratamento do cancro
CL2016000326A1 (es) Composiciones y método para tratar condiciones asociadas con el complemento
PL3277270T3 (pl) Kompozycje i sposoby leczenia niedokrwistości
MX2015011281A (es) Composiciones de inh-c1 y metodos para la prevencion y el tratamiento de trastornos asociados con la deficiencia del inhibidor de c1 esterasa.
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
PL3200815T3 (pl) Sposoby i kompozycje do leczenia nowotworu
UY37017A (es) Inhibidores aza-bencimidazol de pad4
BR112018000776A2 (pt) métodos para tratamento de câncer usando apilimod
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
PL3189074T3 (pl) Kompozycje oraz sposoby leczenia i zapobiegania zapaleniom
MX382904B (es) Combinaciones de fármacos para tratar mieloma múltiple.
ZA201902781B (en) Compositions and methods for the treatment of xerostomia
MX2017006019A (es) Apilimod para uso en el tratamiento de melanoma.
UY36286A (es) Tratamientos médicos basados en anamorelina
MX384259B (es) Composiciones y metodos para tratamiento de crecimiento celular anormal.
PL3373922T3 (pl) Kompozycje i sposoby do stosowania do leczenia homocystynurii

Legal Events

Date Code Title Description
FG Grant or registration